ABSTRACT The anaerobic parasitic protozoa Tritrichomonas foetus is found incapable of de novo pyrimidine biosynthesis by its failure to incorporate bicarbonate, aspartate, or orotate into pyrimidine nucleotides or nucleic acids. Uracil phosphoribosyltransferase in the cytoplasm provides the major pyrimidine salvage for the parasite. Exogenous uridine and cytidine are mostly converted to uracil by uridine phosphorylase and cytidine deaminase in T.
foetu prior to incorporation. T. foetus cannot incorporate labels from exogenous uracil or uridine into DNA; it has no detectable dihydrofolate reductase or thymidylate synthetase and is resistant to methotrexate, pyrimethamine, trimethoprim, and 5-bromovinyldeoxyuridine at millimolar concentrations. It has an enzyme thymidine phosphotransferase in cellular fraction pelleting at 100,000 x g that can convert exogenous thymidine to TMP via a phosphate donor such as p-nitrophenyl phosphate or nucleoside 5'-monophosphate. Thymidine salvage in T. foetus is thus totally dissociated from other pyrimidine salvage.
It has become apparent in recent years that parasitic protozoa are generally incapable of de novo synthesis of purine nucleotides. Trypanosoma cruzi (1), Leishmania donovani (2), Plasmodium lophurae (3), Eimeria tenella (4), and Trichomonas vaginalis (5) , to name but a few examples, depend on specific networks of salvage pathways to fulfill their purine requirements. Because of this deficiency in metabolic activities, rational approaches to controlling some of the parasites have been possible. Allopurinol exhibits antitrypanosomal and antileishmanial activities because it is recognized by the parasite salvage enzymes as a hypoxanthine analog (6, 7) . Allopurinol riboside (8) , formycin B (9) , and 4-thiopyrazolopyrimidine riboside (10) have antileishmanial activities because of the nucleoside phosphotransferase in leishmania, which incorporates the compounds into parasite's nucleotide pool.
De novo pyrimidine biosynthesis, on the other hand, takes place in most of the parasitic protozoa. Recently, it has been reported that the anaerobic flagellates Trichomonas vaginalis and Giardia lamblia may not, however, have even the capability of pyrimidine de novo synthesis. The former lacks aspartate transcarbamoylase, dihydroorotase, dihydroorotate de- hydrogenase, and orotate phosphoribosyltransferase in its crude extract (11) , whereas the latter indicates no incorporation of aspartate into the cold trichloroacetic acid-insoluble fraction (12) . These results suggest that anaerobic flagellates may differ from other protozoan parasites in lacking both purine and pyrimidine de novo synthetic abilities and thus may offer even more opportunities for chemotherapeutic attack.
To verify these possibilities, we studied pyrimidine metabolism in Tritrichomonasfoetus, a cattle parasite that is closely related to Trichomonas vaginalis. Our results show that T. foetus cannot perform de novo pyrimidine synthesis; a very simple scheme of pyrimidine salvage is providing the needs for the parasite.
MATERIALS AND METHODS Cultures. T. foetus strain KV1 was cultivated in Diamond's TYM medium, pH 7.2/10% heat-inactivated horse serum at 370C (13) . Stationary cultures having a cell density of about 2 x 107/ml were used to inoculate fresh media at a 1:10 ratio. indicated, by HPLC analysis, that none of the precursors had been incorporated into the nucleotide pool (data not shown).
Possible precursor incorporation into T. foetus nucleic acids was examined after 2 hr of incubation (Table 1) . No radioactivity from bicarbonate or orotic acid was found in DNA, RNA, or protein. L-Aspartate was incorporated only into protein.
In the phosphoribosyltransferase assays, no orotate phosphoribosyltransferase activity could be detected in extracts (Table 2).
Salvage of Pyrimidines and Pyrimidine Nucleosides. As shown in Fig. 1 , exogenous uracil, uridine, cytidine, and thymidine can be taken up by T.foetus and converted to nucleotides. Uracil incorporation has an initial rate of 1.67 pmol/min per 106 cells, uridine, and cytidine are taken up at a rate that is about 10% of this, and thymidine is incorporated at a rate about 1% of that for uracil. Cytosine and thymine are not incorporated at all. Results of competition experiments between radiolabeled substrates and 10-fold higher concentration of unlabeled substrates are presented in Fig. 2 . Thymine and cytosine, themselves not incorporated, exert no effect on the incorporation of (Fig. 2 A and B) and also with cytidine (Fig. 2C) . Cytidine, however, has little effect on the incorporation of uracil or uridine ( Fig. 2 A and B) . Thymidine incorporation is not affected by any other pyrimidines or pyrimidine nucleosides (Fig. 2D) .
The incorporation of thymidine, uracil, and uridine into T. foetus nucleic acids was examined. The results indicate exclusive incorporation of thymidine into the DNA fraction and of uracil and uridine into the RNA fraction (Table 1 PLC Analysis of Nucleotide Pools. Radiolabeled pyrimidines and pyrimidine nucleosides were used to label T. foetus and then chased with unlabeled substrates. The distribution of radioactivity in the nucleotide pools was analyzed in HPLC. The data indicate the following. (i) Thymidine is converted to TMP, TDP, and TTP. Incorporated radioactivities are rapidly chased off by unlabeled thymidine (Fig. 3). (ii) Uracil and uridine have a similar pattern of incorporation; they are mainly converted to UMP, UDP, UTP, and UDP-hexose. Prolonged chasing reduces the amount of radioactive UMP and increases that of radioactive CTP and CDP (Fig. 4) . (iii) Cytidine is incorporated partly into CMP, CDP, and CTP and partly into UMP, UDP, UTP, and UDP-hexose. A substantial portion of the label can be chased from the CMP, CDP, CTP, and UMP in 30 min (Fig. 5) .
Enzyme Profiles. Enzyme activities found in freshly prepared soluble and pellet fractions of T. foetus extract are summarized in Table 2 . There is no dihydrofolate reductase, thymidylate synthetase, or thymidine kinase detectable in T.foetus. A thymidine phosphotransferase activity was found in the fraction pelleting at 100,000 x g. The product of this enzyme reaction has been identified as TMP by HPLC analysis (data not shown). p-Nitrophenyl phosphate, AMP, GMP, UMP, and CMP are all equally effective phosphate donors when tested at 10 mM whereas sugar phosphates-e.g., fructose 1,6-diphosphate-are inactive. Kinetic studies on the crude enzyme preparation indicated a Km of 10 mM for thymidine. Uridine and cytidine had no effect on the enzyme activity, but guanosine was a noncompetitive inhibitor with an estimated Ki of 1 mM.
Uracil phosphoribosyltransferase is a major enzyme in the supernatant fraction of T. foetus extract. There is also a uridine phosphotransferase in the pellet fraction, but the uridine phosphorylase present may convert most of the uridine to uracil first. The cytidine phosphotransferase detected in T. foetus pellets may be responsible for converting some cytidine directly to CMP. But the presence of cytidine deaminase and uridine phosphorylase in T. foetus suggests also conversion of cytidine to uridine and then to uracil before incorporation into nucleotide. against 20 AM uracil. 5-Fluorouracil (0.5 mM) had no effect on thymidine incorporation into TMP, TDP, and TTP. The incorporation of uracil, uridine, or cytidine into nucleotides was, however, significantly inhibited by the drug. HPLC analysis showed that labeling of all the nucleotides by each of the three substrates was reduced. When 5-fluoro [6-3H] (17) . In view of the inhibition of thymidine phosphotransferase by guanosine, it is not impossible that GMP may be the natural phosphate donor and that the conversion of thymidine to TMP may be dictated by the T. foetus cellular content of GMP. The scheme of pyrimidine salvage networks in T. foetus i § summarized in Fig. 6 .
This simple pyrimidine metabolism in T.foetus has made this parasite one of the most unusual living organisms-not only does it lack de novo pyrimidine synthesis, it also lacks the ubiquitous enzymes dihydrofolate reductase, thymidylate synthetase, and thymidine kinase. Other wild-type organisms are not known to exhibit these deficiencies. The dependence on thymidine phosphotransferase for thymidine salvage also finds. no parallel in other organisms. As mentioned above, there are indications that de novo pyrimidine synthesis may also be absent in Trichomonas vaginalis (11) and G. lamblia (12) . We methotrexate (unpublished data). This family of anaerobic flagellates thus may share the same metabolic deficiencies.
From a pharmacological point of view, it is easy to see how inhibition of thymidine phosphotransferase or uracil phosphoribosyltransferase may lead to inhibition of T.foetus growth (Fig. 6) . 5-Fluorouracil is a moderately competitive inhibitor of uracil phosphoribosyltransferase and also a moderate inhibitor of T. foetus in vitro growth. Although the drug may eventually be incorporated into T. foetus RNA to slow the growth of the organism (because it is converted to 5-fluorouridine triphosphate in T. foetus), its inhibition of incorporation of uracil, uridine, and cytidine also emphasizes the importance of a functioning uracil phosphoribosyltransferase for T.foetus. This enzyme may have unique properties because it has no orotate phosphoribosyltransferase activity and has not been found in most mammalian tissues (18 
